Brief: Paradigm Biopharmaceuticals Says Marco Polizzi Stepped Down As CEO
22/11/2022 24:00
Nov 22 (Reuters) - Paradigm Biopharmaceuticals PAR.AX :
* MARCO POLIZZI, HAS STEPPED DOWN FROM HIS ROLE AS CEO
* PAUL RENNIE APPOINTED AS MANAGING DIRECTOR
* RENNIE WILL CONTINUE TO SERVE AS AN EXECUTIVE CHAIRMAN
* MARCO POLIZZI WILL CEASE EMPLOYMENT WITH CO ON 20 FEBRUARY
2023
Source text for Eikon: ID:nASX6sdn2P
Further company coverage: PAR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt